In a report released on February 11, Brian Abrahams from RBC Capital maintained a Buy rating on Corbus Pharmaceuticals (CRBP – Research ...

Neurocrine stock took a hit late Thursday after the biotech company issued a light 2025 outlook for its drug, Ingrezza.

William Stone; Chairman of the Board, Chief Executive Officer; SS&C Technologies Holdings Inc Rahul Kanwar; President, Chief Operating Officer; SS&C Technologies Holdings Inc Brian Schell; Chief ...

Management projects 2025 revenue between $6.085 billion and $6.245 billion, with organic growth at 5% at the midpoint. Adjusted EPS for the full year is expected to range from $5.64 to $5.96.

CSG expects 2025 revenue to range from $1.21 billion to $1.25 billion, with non-GAAP operating margins between 18.1% and 18.5%. The company anticipates non-GAAP EPS between $4.55 and $4.80 for 2025, ...

ServiceNow reported Q4 earnings that topped estimates but shares fell on lower-than-expected subscription revenue growth in 2025.

What does this Advisor Specialize in? Find a financial advisor who specializes in the area of expertise you require. It's important to find an advisor who can help you approach your personal and ...

On March 28, 2024, RBC completed the purchase of HSBC Bank Canada and its subsidiaries and transitioned HSBC credit card customers to comparable RBC cards. Migrated members who were unhappy with ...

The show, formerly called Brian and Margaret, dramatizes the story of her last ever TV interview, which some believe was the final nail in her prime ministerial coffin. The 45-minute interview was ...

The court heard it was Brian Barnes's first time in custody and that he didn't understand the allegations against him. A 67-year-old man has faced court accused of murdering Merril Kelly in the ...

Macon Blair's remake of low-budget Troma classic The Toxic Avenger, starring Peter Dinklage in the lead role, debuted its first trailer back in October of 2023 before completely dropping off the ...